摘要
The widespread use of Chinese herbal medicine (CHM) and the associated adverse reactions has attracted the attention of researchers and physicians.Reports have shown that several types of CHM can cause liver injury,with increasing numbers of cases reported every year.The difficulty in characterizing CHM-induced liver injury stems from clinical manifestations,diagnosis and pathogenesis.The clinical manifestations are varied,but gastrointestinal symptoms are the majority.The Council for International Organizations of Medical Sciences scale is currently the most commonly used method for assessing causality in cases of medicine-induced liver injury with excellent sensitivity,specificity and predictive validity.However,the pathogenesis of CHM-induced liver injury is not well understood.The classic view encompasses a contribution from "toxic metabolites" that either elicit an immune response or directly affect cellular biochemical processes or functions.In addition,poor quality and inappropriate clinical use of CHMs contribute to safety concerns.To ensure the safe use of CHMs and decrease the number of hepatotoxic cases,clinicians,researchers and pharmaceutical companies should share responsibility by regulating clinical use,strengthening basic toxicology research and establishing a strict quality control system.
